Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Xeloda approved in New Zealand as treatment for colorectal cancer

June 16, 2000

IDM signs cancer vaccine agreement with Sanofi-Synthelabo

June 16, 2000

Synthesis, activity and use of new inhibitors of protein farnesyltransferase

June 15, 2000

Fungally produced compound active against human tumor cell lines

June 15, 2000

Ligand receives approvable letter from FDA for Targretin Gel

June 15, 2000

Agouron and PPD Discovery create anticancer genomics alliance

June 15, 2000

AVI BioPharma demonstrates promise of new telomerase inhibitor

June 15, 2000

Trial of therapeutic agent for myelodysplastic syndrome indicates even greater potential

June 14, 2000

Preparation and use of new thiazole antitumor agents acting on cdk/cyclin complexes

June 13, 2000

U.S. scientists modify RNase A polypeptides to obtain selective cytotoxicity against KS cells

June 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...